Author:
Lau Christopher,Thibodeaux Julie R.,Hanson Roger G.,Narotsky Michael G.,Rogers John M.,Lindstrom Andrew B.,Strynar Mark J.
Publisher
Oxford University Press (OUP)
Reference54 articles.
1. 3M Company. (2003). Environmental and health assessment of perfluorooctanesulfonate and its salts. U.S. EPA. Administrative Record, AR-226-1486.
2. Allen, B. C., Kavlock, R. J., Kimmel, C. A., Faustman, E. M. (1994). Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol.23,487–495.
3. Barnes, D. G., Daston, G. P., Evans, J. S., Jarabek, A. M., Kavlock, R. J., Kimmel, C. A., Park, C., Spitzer, H. L. (1995). Benchmark Dose Workshop: Criteria for use of a benchmark dose to estimate a reference dose. Regul. Toxicol. Pharmacol.21,296–306.
4. Bielmeier, S. R., Best, D. S., and Narotsky, M. G. (2004). Serum hormone characterization and exogeneous hormone rescue of bromodichloromethane-induced pregnancy loss in the F344 rat. Toxicol. Sci.77,101–108.
5. Butenhoff, J. L., Gaylor, D. W., Moore, J. A., Olsen, G. W., Rodricks, J., Mandel, J. H., and Zobel, L. R. (2004a). Characterization of risk for general population exposure to perfluorooctanoate. Reg. Toxicol. Pharmacol.39,363–380.
Cited by
436 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献